Department of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, 4301 W. Markham Street, Little Rock, AR 72205, USA.
Circ Res. 2010 Mar 5;106(4):739-47. doi: 10.1161/CIRCRESAHA.109.206763. Epub 2009 Dec 31.
Calcium channel blockers (CCBs) exert their antihypertensive effect by reducing cardiac afterload but not preload, suggesting that Ca(2+) influx through L-type Ca(2+) channels (LTCC) mediates arterial but not venous tone.
The object of this study was to resolve the mechanism of venous resistance to CCBs.
We compared the sensitivity of depolarization (KCl)-induced constriction of rat small mesenteric arteries (MAs) and veins (MVs) to the dilator effect of CCBs. Initial findings confirmed that nifedipine progressively dilated depolarization-induced constrictions in MAs but not MVs. However, Western blots showed a similar expression of the alpha(1C) pore-forming subunit of the LTCC in both vessels. Patch-clamp studies revealed a similar density of whole-cell Ca(2+) channel current between single smooth muscle cells (SMCs) of MAs and MVs. Based on these findings, we hypothesized that LTCCs are expressed but "silenced" by intracellular Ca(2+) in venous SMCs. After depletion of intracellular Ca(2+) stores by the SERCA pump inhibitor thapsigargin, depolarization-induced constrictions in MVs were blocked 80% by nifedipine suggesting restoration of Ca(2+) influx through LTCCs. Similarly, KCl-induced constrictions were sensitive to block by nifedipine after depletion of intracellular Ca(2+) stores by caffeine, ryanodine, or 2-aminoethoxydiphenyl borate. Cell-attached patch recordings of unitary LTCC currents confirmed rare channel openings during depolarization of venous compared to arterial SMCs, but chelating intracellular Ca(2+) significantly increased the open-state probability of venous LTCCs.
We report that intracellular Ca(2+) inactivates LTCCs in venous SMCs to confer venous resistance to CCB-induced dilation, a fundamental drug property that was previously unexplained.
钙通道阻滞剂(CCBs)通过降低心脏后负荷发挥其降压作用,但不降低前负荷,这表明通过 L 型钙通道(LTCC)的 Ca2+内流介导动脉而非静脉张力。
本研究旨在阐明 CCB 引起静脉阻力的机制。
我们比较了大鼠肠系膜小动脉(MAs)和小静脉(MVs)的去极化(KCl)诱导收缩对 CCB 扩张作用的敏感性。初步发现证实,硝苯地平逐渐扩张 MAs 的去极化诱导收缩,但不扩张 MVs。然而,Western blot 显示两种血管中 LTCC 的α1C 孔形成亚基表达相似。膜片钳研究显示,MAs 和 MVs 单个平滑肌细胞(SMCs)的全细胞 Ca2+通道电流密度相似。基于这些发现,我们假设 LTCC 在静脉 SMC 中表达但被细胞内 Ca2+“沉默”。内质网 Ca2+泵抑制剂 thapsigargin 耗尽细胞内 Ca2+储存后,MAs 中去极化诱导的收缩被硝苯地平阻断 80%,表明 LTCC 介导的 Ca2+内流得到恢复。类似地,用咖啡因、ryanodine 或 2-氨基乙氧基二苯硼酸盐耗尽细胞内 Ca2+储存后,KCl 诱导的收缩对硝苯地平敏感。细胞贴附式膜片钳记录单位 LTCC 电流证实,与动脉 SMC 相比,静脉 SMC 去极化时很少有通道开放,但螯合细胞内 Ca2+显著增加了静脉 LTCC 的开放状态概率。
我们报告细胞内 Ca2+使静脉 SMC 中的 LTCC 失活,从而赋予静脉对 CCB 诱导扩张的阻力,这是一种以前未被解释的基本药物特性。